Symbol
|
PMWLTQ | RMAZ2V | Z0972Z | Z0974Z | Z0973Z | ABZHTQ |
---|---|---|---|---|---|---|
Nom | Multi Reverse Convertible | Multi Vonti | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | Multi Reverse Convertible |
Sous-jacent
|
Amgen Inc. / Lonza Group N / Novartis Sandoz Basket / Pfizer Inc. / Roche AG | Altria Group Inc. / Pfizer Inc. / Philip Morris Intl. Inc. | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | Coca-Cola / Johnson & Johnson / Pfizer Inc. |
Emetteur
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Échéance
|
09.02.2026 | 09.03.2026 | 04.03.2026 | 04.03.2026 | 04.03.2026 | 21.07.2026 |
Ratio | - | - | - | - | - | - |
Prix d'exercise
|
24,49 | 82,22 | 41,9369 | 42,027 | 41,986 | 50,3765 |
rendement max. p.a. | - | - | 15,13% | 19,90% | 17,29% | 9,84% |
Demande | 83,34 | - | - | - | - | 94,48 |
Offre | - | - | - | - | - | 95,28 |